FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Augusto Federici

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Blood Platelets

Physiology

Geographic Areas

Italy

Phenomena

Bleeding Time

Concepts & Ideas

Co-author Network

Publications

TOP 3
J C J Eikenboom; Augusto B Federici; Anne C Goodeve; Jenny Goudemand; Ian R Peake; Francesco Rodeghiero; Reinhard Schneppenheim; Javier Batlle; Ulrich Budde; Maria Teresa Canciani; Giancarlo Castaman; Richard J Dirven
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Augusto B Federici; Jacob H Rand; Ulrich Budde; Giancarlo Castaman; Andreas Tiede
Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update.
Giancarlo Castaman; A Coppola; A Dragani; Augusto B Federici; G Feola; M Franchini; G Gamba; G Mancuso; G Mazzucconi; S Moratelli; M Musso; Piercarla Schinco; S Siragusa; A Tagliaferri; L Valdrè; E Zanon; G Barillari; C Biasoli; E Boeri; M Morfini
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Augusto Federici (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: J C J Eikenboom; Augusto B Federici; Anne C Goodeve; Jenny Goudemand; Ian R Peake; Francesco Rodeghiero; Reinhard Schneppenheim; Javier Batlle; Ulrich Budde; Maria Teresa Canciani; Giancarlo Castaman; Richard J Dirven
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Blood 2013;121(12):2336-9.
2013: Augusto B Federici; Jacob H Rand; Ulrich Budde; Giancarlo Castaman; Andreas Tiede
Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update.
Seminars in thrombosis and hemostasis 2013;39(2):191-201.
2013: Giancarlo Castaman; A Coppola; A Dragani; Augusto B Federici; G Feola; M Franchini; G Gamba; G Mancuso; G Mazzucconi; S Moratelli; M Musso; Piercarla Schinco; S Siragusa; A Tagliaferri; L Valdrè; E Zanon; G Barillari; C Biasoli; E Boeri; M Morfini
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 2013;19(1):82-8.
2012: Maria Solimando; Rosanna Asselta; Luciano Baronciani; Maria Teresa Canciani; Giovanna Cozzi; Augusto B Federici; Silvia La Marca; Flora Peyvandi
Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: Studies of an Italian cohort of 10 patients.
American journal of hematology 2012;87(9):870-4.
2012: Augusto B Federici; Valentina Rossi; Elisabetta Sacchi; Massimo Franchini
Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome?
Blood transfusion = Trasfusione del sangue 2012;10(3):402-3; author reply 404-5.
2012: Augusto B Federici; Chiara Vanelli; Luisa Arrigoni
Transfusion issues in cancer patients.
Thrombosis research 2012;129 Suppl 1():S60-5.
2012: Giancarlo Castaman; Augusto B Federici; S La Marca; P M Mannucci; F Stufano; Alberto Tosetto; Francesco Rodeghiero
Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients.
Journal of thrombosis and haemostasis : JTH 2012;10(4):632-8.
2012: Augusto B Federici; Paula James
Current management of patients with severe von Willebrand disease type 3: a 2012 update.
Acta haematologica 2012;128(2):88-99.
2011: Shaista Nisar; Stephen P Watson; Andrea Artoni; Martina E Daly; Augusto B Federici; Andrew D Mumford; Stuart J Mundell
An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets.
Blood 2011;118(20):5641-51.
2011: Andra H James; Pieter W Kamphuisen; Peter A Kouides; Christine A Lee; Oscar Martínez-Perez; Claire McLintock; Flora Peyvandi; Claire S Philipp; Jeffrey Wilkinson; Rezan Abdul-Kadir; Jennifer E Dietrich; Måns Gustaf Edlund; Augusto B Federici; Susan Halimeh; Rochelle Winikoff
Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel.
European journal of obstetrics, gynecology, and reproductive biology 2011;158(2):124-34.
2011: Augusto B Federici; Alfonso Iorio; Luciano Baronciani; Paolo Bucciarelli; Maria T Canciani; Giancarlo Castaman; Maria G Mazzucconi; Massimo Morfini; Emily Oliovecchio; Angiola Rocino; Mario Schiavoni; Pier M Mannucci
Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.
Seminars in thrombosis and hemostasis 2011;37(5):511-21.
2011: Andreas Tiede; U Budde; Arnold Ganser; Jacob H Rand; Augusto B Federici
How I treat the acquired von Willebrand syndrome.
Blood 2011;117(25):6777-85.
2011: Augusto B Federici
The von Willebrand factor from basic mechanisms to clinical practice.
Blood transfusion = Trasfusione del sangue 2011;9 Suppl 2():s1-2.
2011: S Giannini; M Solimando; T Fierro; Luciano Baronciani; Augusto B Federici; Paolo Gresele
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation.
Thrombosis and haemostasis 2011;105(5):921-4.
2011: Augusto B Federici
Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated.
Seminars in thrombosis and hemostasis 2011;37(1):35-40.
2011: Francesca Pecori Giraldi; Alberto G Ambrogio; Letizia M Fatti; Valentina Rubini; Giovanna Cozzi; Massimo Scacchi; Augusto B Federici; Francesco Cavagnini
Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease.
British journal of clinical pharmacology 2011;71(1):132-6.
2010: Giancarlo Castaman; Alberto Tosetto; Anne C Goodeve; Augusto B Federici; Stefan Lethagen; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; David Habart; Frank Hill; Ian R Peake; Francesco Rodeghiero
The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
British journal of haematology 2010;151(3):245-51.
2010: Giancarlo Castaman; Alberto Tosetto; A Cappelletti; A Goodeve; Augusto B Federici; J Batlle; D Meyer; J Goudemand; J C J Eikenboom; Reinhard Schneppenheim; U Budde; Jørgen Ingerslev; Stefan Lethagen; F Hill; I R Peake; Francesco Rodeghiero
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.
Thrombosis research 2010;126(3):227-31.
2010: N Hickson; D Hampshire; Peter R Winship; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; P James; Ian R Peake; J C J Eikenboom; Anne C Goodeve
von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.
Journal of thrombosis and haemostasis : JTH 2010;8(9):1986-93.
2010: Paquita Nurden; Giuliana Gobbi; Alan Nurden; Jocelyne Enouf; Ibtissam Youlyouz-Marfak; Cecilia Carubbi; Silvia La Marca; Margherita Punzo; Luciano Baronciani; Luigi De Marco; Marco Vitale; Augusto B Federici
Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B.
Blood 2010;115(13):2649-56.
2010: Luciano Baronciani; Flora Peyvandi; M Punzo; S Lancellotti; Maria Teresa Canciani; Augusto B Federici; Raimondo De Cristofaro
Relevance of chloride binding to von Willebrand factor in type 2B von Willebrand disease patients.
Journal of thrombosis and haemostasis : JTH 2010;8(2):416-8.
2010: Augusto B Federici; G Barillari; E Zanon; M G Mazzucconi; R Musso; R Targhetta; Pier M Mannucci
Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16(1):101-10.
2010: Manuela Platè; Stefano Duga; Luciano Baronciani; Silvia La Marca; Valentina Rubini; Pier Mannuccio Mannucci; Augusto B Federici; Rosanna Asselta
Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay.
Haematologica 2010;95(1):172-4.
2009: Peter Kouides; Augusto B Federici; Andra H James; Erik Berntorp; Thomas Abshire; Wolfhart Kreuz
Diagnosis and management of inherited von Willebrand disease in the next decade: panel discussion.
Thrombosis research 2009;124 Suppl 1():S20-1.
2009: Augusto B Federici
Classification of inherited von Willebrand disease and implications in clinical practice.
Thrombosis research 2009;124 Suppl 1():S2-6.
2009: Simona Maria Siboni; Marta Spreafico; L Calò; A Maino; Elena Santagostino; Augusto B Federici; Flora Peyvandi
Gynaecological and obstetrical problems in women with different bleeding disorders.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(6):1291-9.
2009: Paquita Nurden; Alan T Nurden; Silvia La Marca; Margherita Punzo; Luciano Baronciani; Augusto B Federici
Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene.
Haematologica 2009;94(11):1627-9.
2009: Pier M Mannucci; Augusto B Federici; A H James; C M Kessler
von Willebrand disease in the 21st century: current approaches and new challenges.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(5):1154-8.
2009: J C J Eikenboom; L Hilbert; A S Ribba; A Hommais; David Habart; S Messenger; A Al-Buhairan; A Guilliatt; W Lester; Claudine Mazurier; Dominique Meyer; Edith Fressinaud; Ulrich Budde; K Will; Reinhard Schneppenheim; T Obser; O Marggraf; E Eckert; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Jenny Goudemand; Jørgen Ingerslev; Stefan Lethagen; Frank Hill; Ian R Peake; Anne C Goodeve
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study.
Journal of thrombosis and haemostasis : JTH 2009;7(8):1304-12.
2009: Andra H James; Peter A Kouides; Rezan Abdul-Kadir; Måns Gustaf Edlund; Augusto B Federici; Susan Halimeh; Pieter W Kamphuisen; Barbara A Konkle; Oscar Martínez-Perez; Claire McLintock; Flora Peyvandi; Rochelle Winikoff
Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel.
American journal of obstetrics and gynecology 2009;201(1):12.e1-8.
2009: Luciano Baronciani; Augusto B Federici; M Punzo; M Solimando; Guido Cozzi; S La Marca; V Rubini; Maria Teresa Canciani; Pier M Mannucci
Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization.
Journal of thrombosis and haemostasis : JTH 2009;7(7):1114-22.
2009: Augusto B Federici; Maria T Canciani
Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease.
Haematologica 2009;94(5):610-5.
2009: Pier Mannuccio Mannucci; Massimo Franchini; Giancarlo Castaman; Augusto B Federici
Evidence-based recommendations on the treatment of von Willebrand disease in Italy.
Blood transfusion = Trasfusione del sangue 2009;7(2):117-26.
2009: Augusto B Federici
The safety of plasma-derived von Willebrand/factor VIII concentrates in the management of inherited von Willebrand disease.
Expert opinion on drug safety 2009;8(2):203-10.
2009: Augusto B Federici; Pier M Mannucci; Giancarlo Castaman; Luciano Baronciani; Paolo Bucciarelli; Maria Teresa Canciani; Alessandro Pecci; Peter J Lenting; Philip G de Groot
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.
Blood 2009;113(3):526-34.
2008: Augusto B Federici
Clinical and molecular markers of inherited von Willebrand disease type 3: are deletions of the VWF gene associated with alloantibodies to VWF?
Journal of thrombosis and haemostasis : JTH 2008;6(10):1726-8.
2008: Sandra L Haberichter; Giancarlo Castaman; Ulrich Budde; Ian Peake; Anne Goodeve; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank G H Hill; Robert R Montgomery
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
Blood 2008;111(10):4979-85.
2008: Erik Berntorp; William Archey; Günter Auerswald; Augusto B Federici; Massimo Franchini; Sigurd Knaub; Wolfhart Kreuz; Stefan Lethagen; Pier M Mannucci; Hartmut Pollmann; Inge Scharrer; Keith Hoots
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance.
European journal of haematology. Supplementum 2008;(70):3-35.
2008: Luciano Baronciani; Augusto B Federici; Giovanna Cozzi; S La Marca; M Punzo; V Rubini; Maria Teresa Canciani; Pier M Mannucci
Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(3):549-55.
2008: Giancarlo Castaman; Stefan Lethagen; Augusto B Federici; Alberto Tosetto; Anne Goodeve; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Edith Fressinaud; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; John Pasi; Frank Hill; Ian Peake; Francesco Rodeghiero
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
Blood 2008;111(7):3531-9.
2008: Augusto B Federici
Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg?
Journal of thrombosis and haemostasis : JTH 2008;6(4):565-8.
2008: Augusto B Federici
Update on the management of von Willebrand disease.
Clinical advances in hematology & oncology : H&O 2008;6(1):29-30.
2008: Augusto B Federici
The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 1():5-14.
2008: Augusto B Federici; Pier M Mannucci; P Marco
Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(1):133-9.
2007: Augusto B Federici; Giancarlo Castaman; Massimo Franchini; Massimo Morfini; Ezio Zanon; Antonio Coppola; Annarita Tagliaferri; Elio Boeri; Maria Gabriella Mazzucconi; Gina Rossetti; Pier Mannuccio Mannucci
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients.
Haematologica 2007;92(7):944-51.
2007: Montse Piñol; Miquel Sales; Marta Costa; Alberto Tosetto; Maria Teresa Canciani; Augusto B Federici
Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease.
Haematologica 2007;92(5):712-3.
2007: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; M Bernardi; K Bertoncello; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
Journal of thrombosis and haemostasis : JTH 2007;5(4):715-21.
2007: Luciano Baronciani; Augusto B Federici; Giovanna Cozzi; Maria Teresa Canciani; Pier M Mannucci
Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand disease.
Journal of thrombosis and haemostasis : JTH 2007;5(2):282-8.
2007: Augusto B Federici; Pier Mannuccio Mannucci
Management of inherited von Willebrand disease in 2007.
Annals of medicine 2007;39(5):346-58.
2007: Anne C Goodeve; J C J Eikenboom; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; David Habart; Zdena Vorlova; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Mohammad Hashemi Soteh; Luciano Baronciani; Christer Hallden; Andrea M Guilliatt; William A Lester; Ian R Peake
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
Blood 2007;109(1):112-21.
2006: Augusto B Federici; Erik Berntorp; C A Lee
The 80th anniversary of von Willebrand's disease: history, management and research.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(6):563-72.
2006: Raimondo De Cristofaro; Flora Peyvandi; Luciano Baronciani; Roberta Palla; Silvia Lavoretano; Rossana Lombardi; Enrico Di Stasio; Augusto B Federici; Pier Mannuccio Mannucci
Molecular mapping of the chloride-binding site in von Willebrand factor (VWF): energetics and conformational effects on the VWF/ADAMTS-13 interaction.
The Journal of biological chemistry 2006;281(41):30400-11.
2006: Giancarlo Castaman; Francesco Rodeghiero; Alberto Tosetto; A Cappelletti; Francesco Baudo; J C J Eikenboom; Augusto B Federici; Stefan Lethagen; S Linari; Jeanne M Lusher; M Nishino; P Petrini; A Srivastava; J S Ungerstedt
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.
Journal of thrombosis and haemostasis : JTH 2006;4(10):2164-9.
2006: J Evan Sadler; Ulrich Budde; J C J Eikenboom; Emmanuel Favaloro; Frank G H Hill; Lars Holmberg; Jørgen Ingerslev; C A Lee; D Lillicrap; P M Mannucci; Claudine Mazurier; Dominique Meyer; W L Nichols; M Nishino; Ian R Peake; Francesco Rodeghiero; R Schneppenheim; Z M Ruggeri; A Srivastava; R R Montgomery; Augusto B Federici
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.
Journal of thrombosis and haemostasis : JTH 2006;4(10):2103-14.
2006: Zaverio M Ruggeri; Jennifer N Orje; Rolf Habermann; Augusto B Federici; Armin J Reininger
Activation-independent platelet adhesion and aggregation under elevated shear stress.
Blood 2006;108(6):1903-10.
2006: Augusto B Federici
Management of inherited von Willebrand disease in 2006.
Seminars in thrombosis and hemostasis 2006;32(6):616-20.
2006: Augusto B Federici
Diagnosis of inherited von Willebrand disease: a clinical perspective.
Seminars in thrombosis and hemostasis 2006;32(6):555-65.
2006: Luciano Baronciani; Augusto B Federici; Giovanna Cozzi; Maria Teresa Canciani; Pier M Mannucci
von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.
Journal of thrombosis and haemostasis : JTH 2006;4(9):2088-90.
2006: Augusto B Federici; Giancarlo Castaman; A Thompson; Erik Berntorp
Von Willebrand's disease: clinical management.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12 Suppl 3():152-8.
2006: Giuseppe Loffredo; Luciano Baronciani; Patrizia Noris; Francesco Menna; Augusto B Federici; Carlo L Balduini
von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocytopenias with giant platelets.
Platelets 2006;17(3):149-52.
2006: J C J Eikenboom; Vincent Van Marion; H Putter; Anne C Goodeve; Francesco Rodeghiero; Giancarlo Castaman; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD.
Journal of thrombosis and haemostasis : JTH 2006;4(4):774-82.
2006: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Edith Fressinaud; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
Journal of thrombosis and haemostasis : JTH 2006;4(4):766-73.
2006: Augusto B Federici; Elena Santagostino; Maria Grazia Rumi; Antonio Russo; Maria Elisa Mancuso; Roberta Soffredini; Pier M Mannucci; Massimo Colombo
The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study.
Haematologica 2006;91(4):503-8.
2006: Giancarlo Castaman; Augusto B Federici; M Bernardi; B Moroni; K Bertoncello; Francesco Rodeghiero
Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
Journal of thrombosis and haemostasis : JTH 2006;4(2):357-60.
2006: Augusto B Federici
Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders.
Seminars in hematology 2006;43(1 Suppl 1):S48-58.
2006: Thomas J Kunicki; Luciano Baronciani; Maria Teresa Canciani; F Gianniello; Steven R Head; Tony Mondala; Daniel R Salomon; Augusto B Federici
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease type 2A, 2B, and 2M pedigrees.
Journal of thrombosis and haemostasis : JTH 2006;4(1):137-47.
2005: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto; Javier Batlle; Francesco Baudo; A Cappelletti; P Casana; N De Bosch; J C J Eikenboom; Augusto B Federici; Stefan Lethagen; S Linari; A Srivastava
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2619-26.
2005: Luciano Baronciani; Augusto B Federici; Mario Beretta; Giovanna Cozzi; Maria Teresa Canciani; Pier M Mannucci
Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen binding.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2689-94.
2005: Augusto B Federici
Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.
Human immunology 2005;66(4):422-30.
2005: Augusto B Federici
Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16 Suppl 1():S17-21.
2005: Michele Marchese; Raimondo De Cristofaro; Augusto B Federici; Alberto Biondi; Lucio Petruzziello; Andrea Tringali; Cristiano Spada; Massimiliano Mutignani; Paolo Ronconi; Guido Costamagna
Duodenal and gastric Dieulafoy's lesions in a patient with type 2A von Willebrand's disease.
Gastrointestinal endoscopy 2005;61(2):322-5.
2004: Thomas J Kunicki; Augusto B Federici; Daniel R Salomon; James A Koziol; Steven R Head; Tony Mondala; Jeffrey D Chismar; Luciano Baronciani; Maria Teresa Canciani; Ian R Peake
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees.
Blood 2004;104(8):2359-67.
2004: Augusto B Federici
Clinical diagnosis of von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10 Suppl 4():169-76.
2004: Lysiane Hilbert; Augusto B Federici; Luciano Baronciani; Serena Dallagiovanna; Claudine Mazurier
A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications.
Haematologica 2004;89(9):1128-33.
2004: Antonella Lattuada; Luigi Preda; Elisabetta Sacchi; Luciana Gallo; Augusto B Federici; Edoardo Rossi
A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000).
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(6):505-11.
2004: Augusto B Federici; Claudine Mazurier; Erik Berntorp; Christine A Lee; Inge Scharrer; Jenny Goudemand; Stephan Lethagen; Ioana Nitu; Gerard Ludwig; Lysiane Hilbert; Pier M Mannucci
Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.
Blood 2004;103(6):2032-8.
2004: A Srámek; Paolo Bucciarelli; Augusto B Federici; Pier M Mannucci; V De Rosa; Giancarlo Castaman; Massimo Morfini; Maria Gabriella Mazzucconi; Angiola Rocino; Mario Schiavoni; FA Scaraggi; Johan H C Reiber; Frits R Rosendaal
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients.
Circulation 2004;109(6):740-4.
2004: Augusto B Federici; Ulrich Budde; Jacob H Rand
Acquired von Willebrand syndrome 2004: International Registry--diagnosis and management from online to bedside.
Hämostaseologie 2004;24(1):50-5.
2004: Augusto B Federici; Maria Teresa Canciani; Ileana Forza; Pier Mannuccio Mannucci; Patrizia Marchese; Jerry Ware; Zaverio M Ruggeri
A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels.
Haematologica 2004;89(1):77-85.
2003: Augusto B Federici
Mild forms of von Willebrand disease: diagnosis and management.
Current hematology reports 2003;2(5):373-80.
2003: Augusto B Federici
The factor VIII/von Willebrand factor complex: basic and clinical issues.
Haematologica 2003;88(6):EREP02.
2003: Luciano Baronciani; Giovanna Cozzi; Maria Teresa Canciani; Flora Peyvandi; Alok Srivastava; Augusto B Federici; Pier Mannuccio Mannucci
Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients.
Blood cells, molecules & diseases 2003;30(3):264-70.
2003: Augusto B Federici; Pier Mannuccio Mannucci
Diagnosis and management of acquired von Willebrand syndrome.
Clinical advances in hematology & oncology : H&O 2003;1(3):169-75.
2003: Giancarlo Castaman; Augusto B Federici; Francesco Rodeghiero; Pier Mannuccio Mannucci
Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Haematologica 2003;88(1):94-108.
2002: Augusto B Federici; Francesco Baudo; C Caracciolo; Giacomo Mancuso; Maria Gabriella Mazzucconi; Roberto Musso; P C Schinco; R Targhetta; Pier Mannuccio Mannucci
Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi) in the treatment of von Willebrand disease: a retrospective clinical study.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(6):761-7.
2002: Augusto B Federici; Giancarlo Castaman; Pier M Mannucci
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(5):607-21.
2002: Augusto B Federici; Pier Mannuccio Mannucci
Advances in the genetics and treatment of von Willebrand disease.
Current opinion in pediatrics 2002;14(1):23-33.
2001: Pier M Mannucci; Augusto B Federici
Management of inherited von Willebrand disease.
Best practice & research. Clinical haematology 2001;14(2):455-62.
2001: Augusto B Federici; Jacob H Rand; Pier M Mannucci
Acquired von Willebrand syndrome: an important bleeding complication to be considered in patients with lymphoproliferative and myeloproliferative disorders.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(6):358-62.
2000: Augusto B Federici; Maria Teresa Canciani; Ileana Forza; Giovanna Cozzi
Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease--single center comparison of four different assays.
Thrombosis and haemostasis 2000;84(6):1127-8.
2000: Luciano Baronciani; Giovanna Cozzi; Maria Teresa Canciani; Flora Peyvandi; A Srivastava; Augusto B Federici; Pier M Mannucci
Molecular characterization of a multiethnic group of 21 patients with type 3 von Willebrand disease.
Thrombosis and haemostasis 2000;84(4):536-40.
2000: Augusto B Federici; Jacob H Rand; Paolo Bucciarelli; Ulrich Budde; Perry van Genderen; H Mohri; D Meyer; F Rodeghiero; J E Sadler
Acquired von Willebrand syndrome: data from an international registry.
Thrombosis and haemostasis 2000;84(2):345-9.
2000: Augusto B Federici; R Sacco; F Stabile; M Carpenedo; E Zingaro; Pier M Mannucci
Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases.
Haemophilia : the official journal of the World Federation of Hemophilia 2000;6(2):71-7.
1999: Marco Cattaneo; Augusto B Federici; Anna Lecchi; B Agati; Rossana Lombardi; F Stabile; Paolo Bucciarelli
Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease.
Thrombosis and haemostasis 1999;82(1):35-9.
1999: J Di Paola; Augusto B Federici; P M Mannucci; Maria Teresa Canciani; Marcie Kritzik; Thomas J Kunicki; Diane J Nugent
Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system.
Blood 1999;93(11):3578-82.
1999: Augusto B Federici; Pier M Mannucci
Diagnosis and management of von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5 Suppl 2():28-37.
1998: Augusto B Federici; E A D'Amico
The role of von Willebrand factor in the hemostatic defect of acute promyelocytic leukemia.
Leukemia & lymphoma 1998;31(5-6):491-9.
1998: Augusto B Federici; F Stabile; Giancarlo Castaman; Maria Teresa Canciani; Pier M Mannucci
Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.
Blood 1998;92(8):2707-11.
1998: Christine I Chen; Augusto B Federici; Elisabeth M Cramer; Maria Teresa Canciani; P Harrison; Shilun Zheng; Jean-Marc Massé; P M Mannucci; Catherine P M Hayward
Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency.
British journal of haematology 1998;103(1):20-8.
1998: Augusto B Federici
Diagnosis of von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(4):654-60.
1998: Augusto B Federici; Pier M Mannucci
Optimizing therapy with factor VIII/von Willebrand factor concentrates in von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4 Suppl 3():7-10.
1997: Augusto B Federici; Pier M Mannucci; F Stabile; Maria Teresa Canciani; N Di Rocco; S Miyata; Jerry Ware; Zaverio M Ruggeri
A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype.
Thrombosis and haemostasis 1997;78(3):1132-7.
1996: Augusto B Federici; A Falanga; A Lattuada; N Di Rocco; T Barbui; Pier M Mannucci
Proteolysis of von Willebrand factor is decreased in acute promyelocytic leukaemia by treatment with all-trans-retinoic acid.
British journal of haematology 1996;92(3):733-9.
1995: Luigi Bergamaschini; Pier M Mannucci; Augusto B Federici; R Coppola; S Guzzoni; Angelo Agostoni
Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
The Journal of laboratory and clinical medicine 1995;125(3):348-55.
1995: Pier M Mannucci; Augusto B Federici
Antibodies to von Willebrand factor in von Willebrand disease.
Advances in experimental medicine and biology 1995;386():87-92.
1995: Augusto B Federici; Pier M Mannucci; F Stabile; G Rossi; G Piseddu
Orthotopic liver transplantation in a patient with severe hemophilia A: a life-saving treatment for the first Italian case.
International journal of clinical & laboratory research 1995;25(1):44-6.
1993: Augusto B Federici; Pier M Mannucci; E Fogato; P Ghidoni; L Matturri
Autopsy findings in three patients with von Willebrand disease type IIB and type III: presence of atherosclerotic lesions without occlusive arterial thrombi.
Thrombosis and haemostasis 1993;70(5):758-61.
1993: Elena M Faioni; A Krachmalnicoff; S I Bearman; Augusto B Federici; Adriano Decarli; ALESSANDRO MASSIMO GIANNI; G B McDonald; Pier M Mannucci
Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver.
Blood 1993;81(12):3458-62.
1993: Augusto B Federici; Scott Darrell Berkowitz; A Lattuada; Pier M Mannucci
Degradation of von Willebrand factor in patients with acquired clinical conditions in which there is heightened proteolysis.
Blood 1993;81(3):720-5.
1993: Augusto B Federici; P G de Groot; M Moia; M J Ijsseldijk; J J Sixma; Pier M Mannucci
Type I von Willebrand disease, subtype 'platelet low': decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells.
British journal of haematology 1993;83(1):88-93.
1992: P A d'Alessio; G Castaman; F Rodeghiero; H C de Boer; Augusto B Federici; Pier M Mannucci; Philip G de Groot; Jan J Sixma; Jaap-Jan Zwaginga
In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.
Thrombosis research 1992;65(2):221-8.
1992: Augusto B Federici; Scott Darrell Berkowitz; T S Zimmerman; Pier M Mannucci
Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction.
Blood 1992;79(1):38-44.
1990: P d'Alessio; Jaap-Jan Zwaginga; H C de Boer; Augusto B Federici; F Rodeghiero; G Castaman; G Mariani; Pier M Mannucci; Philip G de Groot; Jan J Sixma
Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
Thrombosis and haemostasis 1990;64(2):227-31.
1990: Luigi De Marco; Mario Mazzucato; D De Roia; Alessandra Casonato; Augusto B Federici; A Girolami; Zaverio M Ruggeri
Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
The Journal of clinical investigation 1990;86(3):785-92.
1990: F I Pareti; Augusto B Federici; Marco Cattaneo; Pier M Mannucci
Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb/IIIa.
British journal of haematology 1990;75(1):86-91.
1989: Augusto B Federici; Pier M Mannucci; Rossana Lombardi; A Lattuada; M L Colibretti; J A Dent; T S Zimmerman
Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity.
American journal of hematology 1989;32(4):287-93.
1989: Augusto B Federici; R Bader; S Pagani; M L Colibretti; Luigi De Marco; Pier M Mannucci
Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size.
British journal of haematology 1989;73(1):93-9.
1989: Ricardo Castillo; Gines Escolar; Joan Monteagudo; Antonio Ordinas; M Garrido; M Moia; Augusto B Federici; Pier M Mannucci
Role for platelet von Willebrand factor in supporting platelet-vessel wall interactions in von Willebrand disease.
American journal of hematology 1989;31(3):153-8.
1989: Philip G de Groot; Augusto B Federici; H C de Boer; P d'Alessio; Pier M Mannucci; Jan J Sixma
von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(10):3793-7.
1988: Marco Cattaneo; J F Mustard; Maria Teresa Canciani; M Richardson; Augusto B Federici; Pier M Mannucci
Conditions influencing the interaction of asialo von Willebrand factor with human platelets--the effects of external ionized calcium concentration and the role of arachidonate pathway.
Thrombosis and haemostasis 1988;60(2):280-8.
1988: Augusto B Federici; christophe de romeuf; Philip G de Groot; B Samor; Rossana Lombardi; P D'Alessio; Claudine Mazurier; Pier M Mannucci; Jan J Sixma
Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF).
Blood 1988;71(4):947-52.
1987: Pier M Mannucci; G Tamaro; G Narchi; G Candotti; Augusto B Federici; D Altieri; Francesco Tedesco
Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor.
European journal of haematology 1987;39(5):467-70.
1987: Luigi De Marco; M Mazzuccato; M Grazia Del Ben; U Budde; Augusto B Federici; A Girolami; Zaverio M Ruggeri
Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
The Journal of clinical investigation 1987;80(2):475-82.
1986: Augusto B Federici; Pier M Mannucci; R Bader; Rossana Lombardi; A Lattuada
Heterogeneity in type IIB von Willebrand disease: two unrelated cases with no family history and mild abnormalities of ristocetin-induced interaction between von Willebrand factor and platelets.
American journal of hematology 1986;23(4):381-90.
1986: Pier M Mannucci; Rossana Lombardi; Augusto B Federici; J A Dent; T S Zimmerman; Z M Ruggeri
A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF).
Blood 1986;68(1):269-74.
1985: Pier M Mannucci; Rossana Lombardi; R Bader; L Vianello; Augusto B Federici; S Solinas; Maria Gabriella Mazzucconi; G Mariani
Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.
Blood 1985;66(4):796-802.
1984: Augusto B Federici; J H Elder; Luigi De Marco; Zaverio M Ruggeri; T S Zimmerman
Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.
The Journal of clinical investigation 1984;74(6):2049-55.
1982: Z M Ruggeri; P M Mannucci; Rossana Lombardi; Augusto B Federici; T S Zimmerman
Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
Blood 1982;59(6):1272-8.